Mikkel G. Terp - Concepedia

Concepedia

Author

Mikkel G. Terp

University of Southern Denmark ORCID

Also Known As

Mikkel G Terp, Mikkel G. Terp, Mikkel Green Terp, Mikkel Terp, Terp, Mikkel G.

76

Publications

1.6K

Citations

22

H-Index

56

Concepts

All Affiliations

University of Southern Denmark Odense University Hospital University of Copenhagen Hospital South West Jutland Czech Academy of Sciences

MG

About

Mikkel G. Terp is an author at University of Southern Denmark specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	694
2	Cell Biology	10	10	654
3	Natural Sciences	2	2	61
4	Health Sciences	1	1	79
5	Cellular Therapies	1	1	26

Mikkel G. Terp

×

33

Publications

1.6K

Citations

22

H-Index

	Year	Citations
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation Alexandra Mousset, Enora Lecorgne, Isabelle Bourget, Cancer Cell InflammationCancer ImmunosurveillanceNeutrophil Extracellular TrapsGranulocyteMedicine	2023	214
Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome Sidse Ehmsen, Martin H. Pedersen, Guisong Wang, Cell Reports	2019	175
Anti-Human CD73 Monoclonal Antibody Inhibits Metastasis Formation in Human Breast Cancer by Inducing Clustering and Internalization of CD73 Expressed on the Surface of Cancer Cells Mikkel G. Terp, Kristina A. Olesen, Eva C. Arnspang, The Journal of Immunology Breast OncologyCancer ImmunosurveillanceMedicineCd73 InternalizationImmunology	2013	133
Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2 Soňa Hubáčková, Eliška Davidová, Kateřina Rohlenová, Cell Death and Differentiation	2018	98
Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis Rikke Leth‐Larsen, Mikkel G. Terp, Anne Geske Lindhard Christensen, Molecular Medicine Breast OncologyDistant MetastasisImmunologyHuman Breast CancerFunctional Heterogeneity	2012	79
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer Carla L. Alves, Sidse Ehmsen, Mikkel G. Terp, Nature Communications	2021	77
Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer Abeer J. Al-Qasem, Carla L. Alves, Sidse Ehmsen, npj Precision Oncology Breast OncologyChemoprevention StrategyCancer BiologyTumor BiologyResistance Mechanisms	2022	67
Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer Louise A. Koopman, Mikkel G. Terp, Gijs G. Zom, JCI Insight	2019	54
Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors Soňa Hubáčková, Eliška Davidová, Štěpána Boukalová, Cell Death and Disease	2020	48
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells Mikkel G. Terp, Kirstine Jacobsen, Miguel Ángel Molina‐Vila, npj Precision Oncology	2021	46

Page 1